Skip to main content
Indian Journal of Psychiatry logoLink to Indian Journal of Psychiatry
. 2020 Jul 27;62(4):400–406. doi: 10.4103/psychiatry.IndianJPsychiatry_105_17

Network and pathway enrichment analysis of Attention Deficit/Hyperactivity Disorder candidate genes

Pratichi Singh 1,
PMCID: PMC7597701  PMID: 33165377

Abstract

Background:

Attention deficit/hyperactivity disorder (ADHD) is a well-known multigenic neurodevelopment disorder. It is a psychiatric disease which mainly affects the children and adolescence. Globally, 3%–5% of children are suffering from this mental disorder.

Aims and Objectives:

This disease is characterized by hyperactivity, impulsiveness and inattentiveness. Suffering individuals are also observed with sleep related problems. Though, its polygenic, to study the complexity of these genes, we used a purely network approach. Firstly, we collected all the candidate genes involved in ADHD through a literature survey.

Materials and Methods:

We investigated these genes using STRING 10 and Cytoscape v 3.3.0 for protein protein interaction network. Accordingly, we attempted to identify the hub genes based on definite parameters like betweenness centrality, clustering coefficient and node degree using Network analyzer. Likewise, the key transcriptional regulators were acknowledged by means of MatInspector program. Finally, the enrichment analysis was executed using ClueGO.

Results:

As a result, dopamine receptor D2, brain derived neurotrophic factor, HTRF1A, and dopamine receptor D4 were recognized as hub genes among the reported ADHD genes. While, 17 transcription factors (TFs) were conveyed as the key TFs for these hub genes.

Conclusion:

Functional enrichment analysis revealed regulation of dopamine and behavioral fear response pathways. These pathways have been assumed to play a central role in the ADHD within the selected candidate genes.

Keywords: Attention-deficit/hyperactivity disorder, candidate genes, functional enrichment, protein-protein interaction, transcription factors

INTRODUCTION

Attention-deficit/hyperactivity disorder (ADHD) is the most common psychiatric disorder in children, whereas it is chronic and undiagnosed in adults.[1] Adult ADHD is recently payed attention by the scientists[2,3] as before it was not included as the serious disorder. Basically ADHD is a neurodevelopmental disorder with high prevalence in children especially in US.[4] About 3%–5% in children worldwide are affected, with a high male-to-female ratio.[5] ADHD is a childhood onset disorder as has a drastic effect on the child's growth, functioning, productivity and quality of life ahead.[6,7] There are some features which are observed in the suffering patients, i.e., impairing inattention, frequently inattentive and careless towards works and can be distracted by external stimuli very easily[8,9] hyperactivity, usually have restless feeling and act as driven by motar, impulsiveness, they can't wait or burst out.[8,9] Diagnostic and Statistical Manual of Mental Disorders-IV states that, diagnosis of ADHD can be done on the basis of two different symptoms or either by both, inattentiveness and hyperactivity or impulsivity.[4] Scientist have studied this disorder in a different research field of neuropsychology, neurophysiology, and neuroimaging to understand the deep aspect of the disease relative to the inattentiveness.[10]

The neuropsychological studies were done on animal model to recognize the behavioral response or cognitive response of affected individuals such as controlling, arousal and activation.[11,12] While other model suggests that attention is constituted of three fundamentals i.e., automatic orienting, voluntary orienting and vigilance or alerting.[13,14] Now a day's theories start, including the conclusion of intraindividual variability (IIV) in individuals with ADHD[15,16] which includes the following tests such as attention classrooms,[17] speed, variability, and timing output.[18] The results of the test show that the affected ADHD people had low IIV in reaction time when any reward is considered.[15]

Other then neuropsychological studies, many researches were also done on the animal model. This work explains about the connection between dopamine release in various part of the brain, such as the prefrontal cortex, nucleus accumbens and striatum with the behavior of ADHD.[19] Researcher paid attention towards the dysfunction of the locus coeruleus-norepinephrine system.[20] Many experiments were performed such as electroencephalogram (EEG), it was used to measure the electrical impulses of the brain externally.[21] It showed the abnormal activity of brain networks, which is somehow related to the ADHD.[22] Through this experiment they calculated alpha and delta waves.[23] Alpha waves are involved in brain processing, whereas delta waves are responsible for brain maturation and attention task as well.[23,24] Increase theta waves results in decreased alpha waves.[25] Other experiments were done by magnetoencephalography which clear outs the spatial and temporal of brain activity.[26]

There is a great contribution of neuroimaging studies in understanding inattentiveness character of ADHD patients. Magnetic resonance imaging (MRI) mainly focuses on the brain structure, diffusion tensor imaging (DTI) and functional MRI (FMRI), where structure shows the anatomical composition of the brain, which is followed by the study of disparity in white matter trace through DTI and thermodynamic activation by FMRI.[10] These findings suggest that prefrontal region is responsible for the attention or if get damaged can produce distractibility and poor attentiveness.[27,28] One more factor is involved in the process, i.e., cortico-striato-thalmo-cortical loop, which is a part of thalamus have great impact on ADHD children as this loop regulate the cognitive and emotional activities of brain.[29] FMRI studies have revealed many unidentified areas which are involved in attention related problems. In the recent work of FMRI it describes about the connectivity and networking of the thalamus in the hemisphere. Which directly indicates that failure in a mode of networking in the brain can produce a great defect in the functioning of the thalamus as it responsible in transporting sensory information.[29]

ADHD not only affects the stimuli problems, but it has an adverse effect on sleep also. Many people who are suffering from ADHD are followed by a sleep disorder such as Narcolepsy, Rhythmic Movement Disorder, Delayed Sleep Phase Syndrome, and Obstructive Sleep Apnea.[30] Studies say that about 18.9% of ADHD affected people are suffering from Narcolepsy. These individuals have drowsiness and have a loss of skin shade during emotional challenges.[31] Due to drowsiness automatically there is a loss of attention. While Rhythmic movement is related to the movement of the body like head or body banging before the sleep.[30] Delayed sleep phase syndrome is mainly observed in adolescence and the onset can be seen as insomnia.[32]

Though, ADHD is considered as heritable, despite of this some other finding tries to investigate the other genetic causes of disorder by focusing on the neurodevelopment profile.[33,34] Recent studies are going on to search out the relation between the copy number variations (CNVs) and ADHD, i.e., how CNVs is linked with this disorder after all it is a neurodevelopment misbalance disorder.[35] CNVs refer to large and rare chromosomal excised and duplication[35] which can prove to be a major cause of genetic variation which is somehow related to the neurological defects.[36,37] The limited population of UK with affected individuals was examined for CNVs in which various single nucleotide polymorphisms (SNPs) were genotyped and judge against the control one.[35] According to researcher large number of CNVs was found in the people who were suffering from intellectual related problems.[35] Whereas, no precise chromosome was involved in such cases[37] i.e., the experiment couldn't identify the proper area of aberration involved and sometimes even it does not relate with the disorder.[35,37] Along with it, many evidences show that CNVs is greatly responsible for neurodevelopment diseases such as schizophrenia, and autism.[36,38]

Till now, we discussed about the ADHD disease itself, but the genetic basis of the disease is vaster because this disorder is considered as polygenic in nature. It is needed to understand this multiple gene associated with the disorder in more deep to fight against the disease. Therefore, studies were done to find out the ADHD genes which are explained by various previous reports. The study clarifies about responsible gene and its association. Other information was given by the core data which explains about the SNPs, pathway analysis.[39] Furthermore the genetic factors (transcription factor [TF]) CNV, Variable number tandem repeat (VNTR), and microsatellite, and pathways involved.[39] Large numbers of powerful bioinformatics tools are available to find out the involved genes and how it affects the various biological pathways.[39] We aimed to find out the networking of ADHD genes and analyzed the hub gene based on the largest connection with the other genes. Secondly, the TFs were retrieved which are helpful in regulating these genes. And finally, the enrichment pathways were analyzed for these hub genes.

The concept of network has been announced in systems biology as it exactly tells the inner workings of several multifaceted biological systems.[40] Networking of candidate genes is widely studied for creating gene regulatory networks and listing drug targets by employing the data from GWAS or gene expression.[41,42] Network approach mainly emphases on the interrelationship between the different constituents of protein-protein interaction (PPI) network and the identification of the perceptive molecules linked with the disease.[43] PPI delivers both local as well as the global vision towards the interacting components taking part in similar biological events which can be achieved by biological trials or computational methods.[44] Recently, PPI approach has been promising for drug designing.[45,46]

This study involves the PPI network of the candidate genes important for ADHD genes. For network construction, all candidate genes were taken into account that are involved in ADHD disease. Hence, the present study computes the following work: (a) identifying candidate genes responsible for ADHD genes and generating a network with the help of computational tools, (b) finding hub genes, (c) detecting main transcriptional regulators, (d) generating transcriptional factors, and (e) implementing enrichment analysis to credit the function of hub genes. The transcripional factors helps in regulating the gene. TFs also controls the gene expression, and ensure the correct gene is expressed at the right time and right place (Lodish et al., 2000).[47]

This study highlights the key candidate genes as well as transcription regulators and shows its expression with the help of bioinformatics tools. The study also tells the potential mechanism that is involved in ADHD with the help of genes and pathways present in the network. The outline of the work is shown in Figure 1 and it can also be applied to other diseases.

Figure 1.

Figure 1

Graphical abstract

MATERIALS AND METHODS

Collection of candidate gene

Genes for this study were retrieved from ADHD gene database (http://adhd.psych.ac.cn/). We have found 232 genes to be involved in ADHD.

Protein protein network construction through STRING search

PPI is the physical contact between the two or more proteins which result from electrostatic or biochemical measures.[48] The PPI network helps in the construction of interacted networks from a given query protein or genes. In this study, PPI network was constructed for candidate genes using STRING 10 (Search Tool for the Retrieval of Interacting Genes) database. The STRING database gives the known and the predicted protein interactions, including physical and functional relations which are mainly derived from high throughput experiments, genomic context, co-expression, neighborhood and literature mining.[49]

Network parameter analysis

The PPI network created was visualized by Cytoscape version 3.3.0 software and analyzed with the help of Cytoscape plug-in “Network Analyzer.” To know the hub gene or the functional gene, the topological parameters were set in network analyzer for node degree, betweenness centrality (BC) and clustering coefficient (CC). For a given network, each gene is characterized as a node and the interactions between the genes are known as edges. Node degree is the sum of edges linked to it, therefore, a high degree signifies the hub genes owning chief biological functions. BC shows the importance of a node by the number of small paths passing through each node.[50] The BC of the node is computed as:

BC = Σs≠ n≠ t (σst (n)/σst)      (1)

Where, n is node, s and t are nodes in the network other than node n, σst denotes the number of shortest paths from s to t, and σst (n) is the number of shortest paths from s to t of node n.[51]

Whereas, CC is the number of connected pairs or edges between the nodes. It is defined as follows:

CC = 2en/(kn[kn-1])      (2)

Where, kn is the number of neighbors of node n and en is the number of connected pairs between all neighbors.[52,53]

The value of BC and CC always lies between 0 and 1. Therefore, the decisive network was visualized centred on BC, CC and a node degree, and the hub genes were generated based on higher BC values, CC values, and the node degree with the cut off ≥ 0.005, ≥0.2 and >40 respectively.

Regulatory networking attention-deficit/hyperactivity disorder genes

Promoter analysis was carried out by using MatInspector program, a Genomatix software (GmbH, Michigan, U.S.A) suite to categorize TFs which regulate hub genes. MatInspector program operates the huge archive of matrix descriptions of TF binding sites to trace the matches in DNA sequences.[54]

Functional enrichment analysis

Functional enrichment analysis was performed to comprehend the biological significance of the hub genes and their TFs in ADHD using Cytoscape plugin called “ClueGo” version 2.2.2.[55] ClueGo assists the visualization of functional genes presented as a clustered network and graph using statistical analysis. Two sided hyper geometric test and correction method Bonferroni step-down was used as a statistical test for the enrichment analysis with a kappa score of 0.4.

RESULTS AND DISCUSSION

Network structure of hub genes

PPI network of ADHD genes was designed using STRING. The network gained from STRING was visualized in Cytoscape, and is shown in Figure 2.

Figure 2.

Figure 2

Protein protein interaction network of attention-deficit/hyperactivity disorder candidate genes generated from STRING and visualized in Cytoscape v 3.3.0

Using Network analyzer, the Hub genes were selected with the help of topologies which is restricted to high node degree, higher BC and CC values as described in the methodology. These topology constraints are represented in as a graph and the hub genes with their predefined topologies are presented in Table 1.

Table 1.

Selection of hub genes based on following parameters

Gene BC CC Node degree
DRD2 0.062016 0.350725 46
BDNF 0.120169 0.261616 45
DRD4 0.039625 0.412311 42
HTR1A 0.02825 0.443902 42

BC – Betweenness centrality; CC – Clustering coefficient and node degree with cut off ≥0.05, ≥0.2, and >40 respectively were set as parameters in network analyzer for gene prioritization; BDNF – Brain-derived neurotrophic factor; DRD – Dopamine receptor; HTR1A – 5-hydroxytryptamine (serotonin) receptor 1A

Among 232 ADHD genes, dopamine receptor D2 (DRD2), brain-derived neurotrophic factor (BDNF), dopamine receptor D4 (DRD4), 5-hydroxytryptamine (serotonin) receptor 2A (HTR1A), are regarded as the hub genes (key nodes) exhibiting the utmost connectivity in the network comprising which were categorized under the standard of minimum 40 networks which also describes 1140 edges and 232 nodes. Among these hub genes, DRD2 regarded as a super hub gene as it has the highest node degree which means DRD2 has a maximum number of interacting neighbors or genes. DRD2 and DRD4 are dopamine genes and are highly involved in the dopamine pathway[56] these genes can be easily influenced by the environmental condition therefore the polymorphism is widely studied in these genes.[57,58] DRD4 gene is mainly expressed in the prefrontal cortex of brain.[59] These particular areas of the brain have great importance in behavioral manner, i.e., cognitive action and if found to be affected can lead to severe emotional blockages.[60,61] The other gene with more number of interactions is BDNF. BDNF gene comes under the neurotrophin family. It plays a significant role neurodevelopment pathway which involves the proliferation of the dopaminergic neuron cells.[62] Evidences show that this gene is present in the piriform cortex hypothalamus and amygdala of rats, which somehow shows its association with the stimulus and response process.[63] The fourth hub gene is serotonin dependent gene HTR1A. Serotonin dysfunction may lead to the aggressive attitude.[64] HTR1A receptor shows affinity towards the endogenous neurotransmitter serotonin.[65] These are available in large quantity in human nervous system such as, raphe nucleus septum hippocampus, and cerebral cortex. This receptor have some impact on dopamine secretion in above explained brain areas.[65]

Hub genes are possibly considered as functionally significant when compared to other genes, as it has the largest number of connections.[66] It has been confirmed that deletion of any of the hub gene creates a maximum frequency of disease phenotypes than the deletion of any normal gene which shows less interaction.[53] This property progresses the understanding of hub or key genes linked to the diseases.

Predicted key regulatory transcription factors

Transcriptional regulators of these hub genes (DRD2, BDNF, DRD4, HTR1A) were identified using MatInspector program. A list was generated for each hub gene displaying common TFs. TFs found to be common in these hub genes are ZBED4.02 (Zinc finger, BED-type containing 4; polyG binding sites), ZBED4.01 ( Zinc finger, BED-type containing 4; GC-box binding sites), E2F1.01 (E2F TF 1), WT1.0 (Wilms Tumor Suppressor), EGR2.02 (Egr-2/Krox-20 early growth response gene product), CKROX.01 Collagen krox protein (zinc finger protein 67-zfp67), KLF6.01 (Core promoter-binding protein with 3 Krueppel-type zinc fingers (KLF6, ZF9)), VMYB.05 ( v-Myb, variant of AMV v-myb), MZF1.01 (Myeloid zinc finger protein), NM23.01 (NME/NM23 nucleoside diphosphate kinase1 and 2), PLAG1.01 (Pleomorphic adenoma gene (PLAG) 1, a developmentally regulated C2H2 zinc finger protein), SP1.03 (Stimulating protein 1, ubiquitous zinc finger transcription facto) r, ZKSCAN3.01 ( Zinc finger with KRAB and SCAN domains 3), ZBP89.01 (Zinc finger TF ZBP-89), ZNF202.01 (Zinc finger protein 202), ZNF263.01 (Zinc finger protein 263), ZKSCAN12 (zinc finger protein with KRAB and SCAN domains 12). This indicates that these TFs might play a crucial role in regulating these ADHD hub genes.

Enrichment through ontology

Functional enrichment analysis of ADHD genes was performed using the “ClueGo” software for the better understanding of pathways involved in the hub genes and their key transcriptional regulators. The pathways involved in these hub genes are “Dopamine metabolic pathways” and “behavioral fear response pathway” shown in Figures 3 and 4.

Figure 3.

Figure 3

A combination of network and enrichment analysis using ClueGo

Figure 4.

Figure 4

Gene ontologies involved in the hub genes and their transcriptional factors

Many environmental factors are seen to incriminate the neurotransmitter dopamine which is supposed to be associated with ADHD. Mainly the genes which can alter the dopamine pathway are DRD4 and DRD2. The study suggests that on the brain, dopamine neurotransmitter affects the ADHD to a very great extent. It is experimented that the dopamine neurotransmitter deficit may face motivational issues.[67,68] It also states that mesoaccumbens dopamine pathways (these are dopamine cells, which are present in the midbrain and have projection) which may be altered and results in ADHD.[69,70] This study concludes that dopamine reward pathways as to be one of the reasons of inattentiveness in ADHD.

The other pathway which is prone by the affected genes is behavioral fear response. Many examinations were done to understand and relate the fear response pathway with ADHD. Research are still going on to understand the connection however, by physiological point of view inhibition response is very poor[71,72] and considered as the key point for ADHD and inhibits the working procedure and operate the other process in between include amygdale, raphe nucleus, septohippocampal system, hypothalamus, locus ceruleus, and neurocircuitry incorporating the frontal cortex.[72,73,74] Faulty, BIS process unsuccessful to cooperate with normal, adaptive activation responses and normal stress action which comes out as a fearful reinforcement.[73]

CONCLUSION

In this study, we investigated ADHD interacting proteins to model the PPI network. Hub genes (DRD2, BDNF, DRD4, HTR1A) were identified along with their common TFs. Functional enrichment analysis revealed 'dopamine metabolic pathways' and “behavioral fear response pathway” to play a central role within the selected ADHD hub genes. Any mutation in these hub genes and TFs may alter the phenotype of gene or protein, which is already reported in previous reports.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

REFERENCES

  • 1.Wender PH, Wolf LE, Wasserstein J. Adults with ADHD. Ann New York Acad Sci. 2001;931:1–16. [PubMed] [Google Scholar]
  • 2.Weiss G, Hechtman LT. Hyperactive Children Grown Up: ADHD in Children, Adolescents, and Adults. Washington: Guilford Press; 1993. [Google Scholar]
  • 3.Pary R, Lewis S, Matuschka PR, Rudzinskiy P, Safi M, Lippmann S. Attention deficit disorder in adults. Ann Clin Psychiatry. 2002;14:105–11. doi: 10.1023/a:1016807021779. [DOI] [PubMed] [Google Scholar]
  • 4.Hodgkins P, Montejano L, Sasané R, Huse D. Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: A retrospective analysis. Prim Care Companion CNS Disord. 2011:13. doi: 10.4088/PCC.10m01030. PCC10m01030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Pennington BF. The Development of Psychopathology: Nature and Nurture. New York: Guilford Press; 2002. [Google Scholar]
  • 6.Safren SA, Sprich SE, Cooper-Vince C, Knouse LE, Lerner JA. Life impairments in adults with medication-treated ADHD. J Atten Disord. 2010;13:524–31. doi: 10.1177/1087054709332460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Barkley RA, Cook EH, Dulcan M, Campbell S, Prior M, Atkins M, et al. Consensus statement on ADHD. Eur Child Adolesc Psychiatry. 2002 [Google Scholar]
  • 8.MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. Pediatrics. 2004;113:754–61. doi: 10.1542/peds.113.4.754. [DOI] [PubMed] [Google Scholar]
  • 9.American Psychiatric Association and American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM) Washington, DC: American Psychiatric Association; 1994. pp. 143–7. [Google Scholar]
  • 10.Sroubek A, Kelly M, Li X. Inattentiveness in attention-deficit/hyperactivity disorder. Neurosci Bull. 2013;29:103–10. doi: 10.1007/s12264-012-1295-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sergeant J. The cognitive-energetic model: An empirical approach to attention-deficit hyperactivity disorder. Neurosci Biobehav Rev. 2000;24:7–12. doi: 10.1016/s0149-7634(99)00060-3. [DOI] [PubMed] [Google Scholar]
  • 12.Sanders AF. Towards a model of stress and human performance. Acta Psychol (Amst) 1983;53:61–97. doi: 10.1016/0001-6918(83)90016-1. [DOI] [PubMed] [Google Scholar]
  • 13.Berger A, Posner MI. Pathologies of brain attentional networks. Neurosci Biobehav Rev. 2000;24:3–5. doi: 10.1016/s0149-7634(99)00046-9. [DOI] [PubMed] [Google Scholar]
  • 14.Huang-Pollock CL, Nigg JT. Searching for the attention deficit in attention deficit hyperactivity disorder: The case of visuospatial orienting. Clin Psychol Rev. 2003;23:801–30. doi: 10.1016/s0272-7358(03)00073-4. [DOI] [PubMed] [Google Scholar]
  • 15.Kuntsi J, Klein C. Intraindividual variability in ADHD and its implications for research of causal links. Curr Top Behav Neurosci. 2011;9:67–91. doi: 10.1007/7854_2011_145. [DOI] [PubMed] [Google Scholar]
  • 16.Castellanos FX, Tannock R. Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes. Nat Rev Neurosci. 2002;3:617–28. doi: 10.1038/nrn896. [DOI] [PubMed] [Google Scholar]
  • 17.Rapport MD, Kofler MJ, Alderson RM, Timko TM, Jr, Dupaul GJ. Variability of attention processes in ADHD: Observations from the classroom. J Atten Disord. 2009;12:563–73. doi: 10.1177/1087054708322990. [DOI] [PubMed] [Google Scholar]
  • 18.Rommelse NN, Altink ME, Oosterlaan J, Beem L, Buschgens CJ, Buitelaar J, et al. Speed, variability, and timing of motor output in ADHD: Which measures are useful for endophenotypic research? Behav Genet. 2008;38:121–32. doi: 10.1007/s10519-007-9186-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Davids E, Zhang K, Tarazi FI, Baldessarini RJ. Animal models of attention-deficit hyperactivity disorder. Brain Res Brain Res Rev. 2003;42:1–21. doi: 10.1016/s0165-0173(02)00274-6. [DOI] [PubMed] [Google Scholar]
  • 20.Mullane JC, Corkum PV, Klein RM, McLaughlin EN, Lawrence MA. Alerting, orienting, and executive attention in children with ADHD. J Atten Disord. 2010;15:310–20. doi: 10.1177/1087054710366384. [DOI] [PubMed] [Google Scholar]
  • 21.Ebner A, Sciarretta G, Epstein CM, Nuwer M. EEG instrumentation. The International federation of clinical neurophysiology. Electroencephalogr Clin Neurophysiol Suppl. 1999;52:7. [PubMed] [Google Scholar]
  • 22.Broyd SJ, Helps SK, Sonuga-Barke EJ. Attention-induced deactivations in very low frequency EEG oscillations: Differential localisation according to ADHD symptom status. PLoS One. 2011;6:e17325. doi: 10.1371/journal.pone.0017325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Nazari MA, Wallois F, Aarabi A, Berquin P. Dynamic changes in quantitative electroencephalogram during continuous performance test in children with attention-deficit/hyperactivity disorder. Int J Psychophysiol. 2011;81:230–6. doi: 10.1016/j.ijpsycho.2011.06.016. [DOI] [PubMed] [Google Scholar]
  • 24.Noachtar S, Binnie C, Ebersole J, Mauguière F, Sakamoto A, Westmoreland B. A glossary of terms most commonly used by clinical electroencephalographers and proposal for the report form for the EEG findings. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl. 2004;52:21–41. [PubMed] [Google Scholar]
  • 25.Bush G, Valera EM, Seidmawn LJ. Functional neuroimaging of attention-deficit/hyperactivity disorder: A review and suggested future directions. Biol Psychiatry. 2005;57:1273–84. doi: 10.1016/j.biopsych.2005.01.034. [DOI] [PubMed] [Google Scholar]
  • 26.Dockstader C, Gaetz W, Cheyne D, Wang F, Castellanos FX, Tannock R. MEG event-related desynchronization and synchronization deficits during basic somatosensory processing in individuals with ADHD. Behav Brain Funct. 2008;4:8. doi: 10.1186/1744-9081-4-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kobel M, Bechtel N, Specht K, Klarhöfer M, Weber P, Scheffler K, et al. Structural and functional imaging approaches in attention deficit/hyperactivity disorder: Does the temporal lobe play a key role? Psychiatry Res. 2010;183:230–6. doi: 10.1016/j.pscychresns.2010.03.010. [DOI] [PubMed] [Google Scholar]
  • 28.Krain AL, Castellanos FX. Brain development and ADHD. Clin Psychol Rev. 2006;26:433–44. doi: 10.1016/j.cpr.2006.01.005. [DOI] [PubMed] [Google Scholar]
  • 29.Xia S, Li X, Kimball AE, Kelly MS, Lesser I, Branch C. Thalamic shape and connectivity abnormalities in children with attention-deficit/hyperactivity disorder. Psychiatry Res. 2012;204:161–7. doi: 10.1016/j.pscychresns.2012.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Walters AS, Silvestri R, Zucconi M, Chandrashekariah R, Konofal E. Review of the possible relationship and hypothetical links between attention deficit hyperactivity disorder (ADHD) and the simple sleep related movement disorders, parasomnias, hypersomnias, and circadian rhythm disorders. J Clin Sleep Med. 2008;4:591–600. [PMC free article] [PubMed] [Google Scholar]
  • 31.Oosterloo M, Lammers GJ, Overeem S, de Noord I, Kooij JJ. Possible confusion between primary hypersomnia and adult attention-deficit/hyperactivity disorder. Psychiatry Res. 2006;143:293–7. doi: 10.1016/j.psychres.2006.02.009. [DOI] [PubMed] [Google Scholar]
  • 32.Van der Heijden KB, Smits MG, Someren EJ, Gunning WB. Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: A circadian rhythm sleep disorder. Chronobiol Int. 2005;22:559–70. doi: 10.1081/CBI-200062410. [DOI] [PubMed] [Google Scholar]
  • 33.Timimi S, Taylor E. ADHD is best understood as a cultural construct. Br J Psychiatry. 2004;184:8–9. doi: 10.1192/bjp.184.1.8. [DOI] [PubMed] [Google Scholar]
  • 34.Amaral OB. Psychiatric disorders as social constructs: ADHD as a case in point. Am J Psychiatry. 2007;164:1612. doi: 10.1176/appi.ajp.2007.07060942. [DOI] [PubMed] [Google Scholar]
  • 35.Williams NM, Franke B, Mick E, Anney RJ, Freitag CM, Gill M, et al. Genome-wide analysis of copy number variants in attention deficit hyperactivity disorder: The role of rare variants and duplications at 15q13.3. Am J Psychiatry. 2012;169:195–204. doi: 10.1176/appi.ajp.2011.11060822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Abrahams BS, Geschwind DH. Advances in autism genetics: On the threshold of a new neurobiology. Nat Rev Genet. 2008;9:341–55. doi: 10.1038/nrg2346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009;459:569–73. doi: 10.1038/nature07953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Kirov G, Grozeva D, Norton N, Ivanov D, Mantripragada KK, Holmans P, et al. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet. 2009;18:1497–503. doi: 10.1093/hmg/ddp043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Zhang L, Chang S, Li Z, Zhang K, Du Y, Ott J, et al. ADHDgene: A genetic database for attention deficit hyperactivity disorder. Nucleic Acids Res. 2012;40:D1003–9. doi: 10.1093/nar/gkr992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Jeong H, Tombor B, Albert R, Oltvai ZN, Barabási AL. The large-scale organization of metabolic networks. Nature. 2000;407:651–4. doi: 10.1038/35036627. [DOI] [PubMed] [Google Scholar]
  • 41.Chen BS, Yang SK, Lan CY, Chuang YJ. A systems biology approach to construct the gene regulatory network of systemic inflammation via microarray and databases mining. BMC Med Genomics. 2008;1:46. doi: 10.1186/1755-8794-1-46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kaimal V, Sardana D, Bardes EE, Gudivada RC, Chen J, Jegga AG. Integrative systems biology approaches to identify and prioritize disease and drug candidate genes. Methods Mol Biol. 2011;700:241–59. doi: 10.1007/978-1-61737-954-3_16. [DOI] [PubMed] [Google Scholar]
  • 43.Nair J, Ghatge M, Kakkar VV, Shanker J. Network analysis of inflammatory genes and their transcriptional regulators in coronary artery disease. PLoS One. 2014;9:e94328. doi: 10.1371/journal.pone.0094328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Guimarães KS, Przytycka TM. Protein-protein Interactions and Networks. London: Springer; 2008. Protein interaction network based prediction of domain-domain and domain-peptide interactions; pp. 83–98. [Google Scholar]
  • 45.Huang J, Schreiber SL. A yeast genetic system for selecting small molecule inhibitors of protein-protein interactions in nanodroplets. Proc Natl Acad Sci U S A. 1997;94:13396–401. doi: 10.1073/pnas.94.25.13396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Arkin MR, Wells JA. Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream. Nat Rev Drug Discov. 2004;3:301–17. doi: 10.1038/nrd1343. [DOI] [PubMed] [Google Scholar]
  • 47.Lodish H, Berk A, Zipursky SL, et al. Molecular Cell Biology. 4th edition. New York: W H Freeman; 2000. [Google Scholar]
  • 48.De Las Rivas J, Fontanillo C. Protein-protein interactions essentials: Key concepts to building and analyzing interactome networks. PLoS Comput Biol. 2010;6:e1000807. doi: 10.1371/journal.pcbi.1000807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2014;43:D447–52. doi: 10.1093/nar/gku1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Assenov Y, Ramírez F, Schelhorn SE, Lengauer T, Albrecht M. Computing topological parameters of biological networks. Bioinformatics. 2008;24:282–4. doi: 10.1093/bioinformatics/btm554. [DOI] [PubMed] [Google Scholar]
  • 51.Brandes U. A faster algorithm for betweenness centrality. J Mathemat Sociol. 2001;25:163–77. [Google Scholar]
  • 52.Watts DJ, Strogatz SH. Collective dynamics of 'small-world'networks. Nature. 1998;393:440–2. doi: 10.1038/30918. [DOI] [PubMed] [Google Scholar]
  • 53.Barabasi AL, Oltvai ZN. Network biology: Understanding the cell's functional organization. Nature Rev Genet. 2004;5:101–13. doi: 10.1038/nrg1272. [DOI] [PubMed] [Google Scholar]
  • 54.Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, et al. MatInspector and beyond: Promoter analysis based on transcription factor binding sites. Bioinformatics. 2005;21:2933–42. doi: 10.1093/bioinformatics/bti473. [DOI] [PubMed] [Google Scholar]
  • 55.Bulyk ML, Johnson PL, Church GM. Nucleotides of transcription factor binding sites exert interdependent effects on the binding affinities of transcription factors. Nucleic Acids Res. 2002;30:1255–61. doi: 10.1093/nar/30.5.1255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Kustanovich V, Ishii J, Crawford L, Yang M, McGough JJ, McCracken JT, et al. Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: Confirmation of association of ADHD with DRD4 and DRD5. Mol Psychiatry. 2004;9:711–7. doi: 10.1038/sj.mp.4001466. [DOI] [PubMed] [Google Scholar]
  • 57.Rowe DC, Van den Oord EJ, Stever C, Giedinghagen LN, Gard JM, Cleveland HH, et al. The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder. Molecular Psychiatry. 1999;4):580–6. doi: 10.1038/sj.mp.4000567. [DOI] [PubMed] [Google Scholar]
  • 58.Tahir E, Yazgan Y, Cirakoglu B, Ozbay F, Waldman I, Asherson PJ. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol Psychiatry. 2000;5:396–404. doi: 10.1038/sj.mp.4000744. [DOI] [PubMed] [Google Scholar]
  • 59.Meador-Woodruff JH, Damask SP, Wang J, Haroutunian V, Davis KL, Watson SJ. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology. 1996;15:17–29. doi: 10.1016/0893-133X(95)00150-C. [DOI] [PubMed] [Google Scholar]
  • 60.Rapport LJ, Van Voorhis A, Tzelepis A, Friedman SR. Executive functioning in adult attention-deficit hyperactivity disorder. Clin Neuropsychol. 2001;15:479–91. doi: 10.1076/clin.15.4.479.1878. [DOI] [PubMed] [Google Scholar]
  • 61.Rubia K, Overmeyer S, Taylor E, Brammer M, Williams SC, Simmons A, et al. Functional frontalisation with age: Mapping neurodevelopmental trajectories with fMRI. Neurosci Biobehav Rev. 2000;24:13–9. doi: 10.1016/s0149-7634(99)00055-x. [DOI] [PubMed] [Google Scholar]
  • 62.Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 1991;350:230–2. doi: 10.1038/350230a0. [DOI] [PubMed] [Google Scholar]
  • 63.Meredith GE, Callen S, Scheuer DA. Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration. Brain Res. 2002;949:218–27. doi: 10.1016/s0006-8993(02)03160-8. [DOI] [PubMed] [Google Scholar]
  • 64.Hsu CD, Tzang RF, Liou YJ, Hong CJ, Tsai SJ. Family-based association study of tryptophan hydroxylase 2 and serotonin 1A receptor genes in attention deficit hyperactivity disorder. Psychiatr Genet. 2013;23:38. doi: 10.1097/YPG.0b013e3283586378. [DOI] [PubMed] [Google Scholar]
  • 65.Zuo L, Saba L, Lin X, Tan Y, Wang K, Krystal JH, et al. Significant association between rare IPO11-HTR1A variants and attention deficit hyperactivity disorder in Caucasians. Am J Med Genet Part B Neuropsychiat Genetics. 2015;168:544–56. doi: 10.1002/ajmg.b.32329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Jeong H, Mason SP, Barabási AL, Oltvai ZN. Lethality and centrality in protein networks. Nature. 2001;411:41–2. doi: 10.1038/35075138. [DOI] [PubMed] [Google Scholar]
  • 67.Sonuga-Barke EJ. The dual pathway model of AD/HD: An elaboration of neuro-developmental characteristics. Neurosci Biobehav Rev. 2003;27:593–604. doi: 10.1016/j.neubiorev.2003.08.005. [DOI] [PubMed] [Google Scholar]
  • 68.Sonuga-Barke EJ. Causal models of attention-deficit/hyperactivity disorder: From common simple deficits to multiple developmental pathways. Biol Psychiatry. 2005;57:1231–8. doi: 10.1016/j.biopsych.2004.09.008. [DOI] [PubMed] [Google Scholar]
  • 69.Wise RA. Brain reward circuitry: Insights from unsensed incentives. Neuron. 2002;36:229–40. doi: 10.1016/s0896-6273(02)00965-0. [DOI] [PubMed] [Google Scholar]
  • 70.Barkley RA. Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull. 1997;121:65–94. doi: 10.1037/0033-2909.121.1.65. [DOI] [PubMed] [Google Scholar]
  • 71.Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002;111:279–89. [PubMed] [Google Scholar]
  • 72.Morris TL, March JS, editors . Anxiety Disorders in Children and Adolescents. New York, London: Guilford Press; 2004. [Google Scholar]
  • 73.Quay HC. Inhibition and attention deficit hyperactivity disorder. J Abnormal Child Psychol. 1997;25:7–13. doi: 10.1023/a:1025799122529. [DOI] [PubMed] [Google Scholar]
  • 74.Chang CH, Yu CJ, Du JC, Chiou HC, Chen HC, Yang W, et al. The interactions among organophosphate pesticide exposure, oxidative stress, and genetic polymorphisms of dopamine receptor D4 increase the risk of attention deficit/hyperactivity disorder in children. Environ Res. 2018;160:339–46. doi: 10.1016/j.envres.2017.10.011. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Psychiatry are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES